Podcast
Questions and Answers
According to the American College of Gastroenterology, what is the recommended management for patients with unresectable extrahepatic biliary strictures?
According to the American College of Gastroenterology, what is the recommended management for patients with unresectable extrahepatic biliary strictures?
- Placing both covered and uncovered self-expandable metal stents (SEMS)
- Placing covered self-expandable metal stents (SEMS)
- Placing plastic stents
- Placing uncovered self-expandable metal stents (SEMS) (correct)
What is the goal of hepatobiliary drainage for patients with malignant hilar strictures?
What is the goal of hepatobiliary drainage for patients with malignant hilar strictures?
- Draining less than 50% of the liver
- Draining more than 50% of the liver (correct)
- Draining exactly 50% of the liver
- Draining the entire liver
In a randomized trial, what was the outcome of rifabutin triple therapy compared to bismuth quadruple therapy for Helicobacter pylori?
In a randomized trial, what was the outcome of rifabutin triple therapy compared to bismuth quadruple therapy for Helicobacter pylori?
- Neither therapy had satisfactory eradication rates
- Rifabutin triple therapy had higher eradication rates
- Both therapies had similar eradication rates (correct)
- Bismuth quadruple therapy had higher eradication rates
According to an observational study, what is the risk of developing liver cancer associated with higher intake of sugar-sweetened beverages?
According to an observational study, what is the risk of developing liver cancer associated with higher intake of sugar-sweetened beverages?
What is the main recommendation of the American Association for the Study of Liver Diseases (AASLD) for patients with nonalcohol-associated fatty liver disease (NAFLD)?
What is the main recommendation of the American Association for the Study of Liver Diseases (AASLD) for patients with nonalcohol-associated fatty liver disease (NAFLD)?
Which surgical procedure resulted in the highest rate of resolution without worsening fibrosis after one year in patients with nonalcoholic steatohepatitis (NASH)?
Which surgical procedure resulted in the highest rate of resolution without worsening fibrosis after one year in patients with nonalcoholic steatohepatitis (NASH)?
Which surgical procedure resulted in the highest rate of improvement in fibrosis without worsening NASH after one year in patients with nonalcoholic steatohepatitis (NASH)?
Which surgical procedure resulted in the highest rate of improvement in fibrosis without worsening NASH after one year in patients with nonalcoholic steatohepatitis (NASH)?
Which surgical procedure was associated with lower risks of new-onset heart failure, cardiovascular events, cerebrovascular events, coronary artery interventions, and all-cause mortality in patients with nonalcoholic fatty liver disease (NAFLD)?
Which surgical procedure was associated with lower risks of new-onset heart failure, cardiovascular events, cerebrovascular events, coronary artery interventions, and all-cause mortality in patients with nonalcoholic fatty liver disease (NAFLD)?
What adverse events have been associated with selective androgen receptor modulators (SARMs)?
What adverse events have been associated with selective androgen receptor modulators (SARMs)?
What is the recommended initial therapy for managing biliary strictures in liver transplantation recipients?
What is the recommended initial therapy for managing biliary strictures in liver transplantation recipients?
Which of the following is true regarding the risk of post-sphincterotomy bleeding in patients on antithrombotic therapy undergoing endoscopic retrograde cholangiopancreatography (ERCP)?
Which of the following is true regarding the risk of post-sphincterotomy bleeding in patients on antithrombotic therapy undergoing endoscopic retrograde cholangiopancreatography (ERCP)?
What should be considered when managing periprocedural antithrombotic agents in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP)?
What should be considered when managing periprocedural antithrombotic agents in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP)?
Which of the following is NOT mentioned as a factor to consider when managing periprocedural antithrombotic agents in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP)?
Which of the following is NOT mentioned as a factor to consider when managing periprocedural antithrombotic agents in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP)?
What is the magnitude of risk for post-sphincterotomy bleeding in patients on antiplatelet agents undergoing endoscopic retrograde cholangiopancreatography (ERCP)?
What is the magnitude of risk for post-sphincterotomy bleeding in patients on antiplatelet agents undergoing endoscopic retrograde cholangiopancreatography (ERCP)?
What is the magnitude of risk for post-sphincterotomy bleeding in patients on anticoagulants undergoing endoscopic retrograde cholangiopancreatography (ERCP)?
What is the magnitude of risk for post-sphincterotomy bleeding in patients on anticoagulants undergoing endoscopic retrograde cholangiopancreatography (ERCP)?
Which therapy resulted in higher rates of clinical remission after 12 weeks in the induction phase trial for moderate to severe ulcerative colitis?
Which therapy resulted in higher rates of clinical remission after 12 weeks in the induction phase trial for moderate to severe ulcerative colitis?
What percentage of patients responded to induction therapy in the maintenance phase trial for mirikizumab?
What percentage of patients responded to induction therapy in the maintenance phase trial for mirikizumab?
Which therapy resulted in higher rates of clinical remission after 12 weeks in the induction phase trial for moderate to severe ulcerative colitis in patients who had inadequate or loss of response to prior therapy?
Which therapy resulted in higher rates of clinical remission after 12 weeks in the induction phase trial for moderate to severe ulcerative colitis in patients who had inadequate or loss of response to prior therapy?
Which therapy resulted in higher rates of sustained clinical remission after 52 weeks in the maintenance phase trial for moderate to severe ulcerative colitis?
Which therapy resulted in higher rates of sustained clinical remission after 52 weeks in the maintenance phase trial for moderate to severe ulcerative colitis?
For which condition did the US Food and Drug Administration approve upadacitinib as an option for second-line therapy?
For which condition did the US Food and Drug Administration approve upadacitinib as an option for second-line therapy?
